7-146760775-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_014141.6(CNTNAP2):c.98-13496G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.354 in 151,404 control chromosomes in the GnomAD database, including 11,000 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.35 ( 11000 hom., cov: 29)
Consequence
CNTNAP2
NM_014141.6 intron
NM_014141.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.84
Publications
2 publications found
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
- cortical dysplasia-focal epilepsy syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.567 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CNTNAP2 | NM_014141.6 | c.98-13496G>C | intron_variant | Intron 1 of 23 | ENST00000361727.8 | NP_054860.1 | ||
| CNTNAP2 | XM_017011950.3 | c.98-13496G>C | intron_variant | Intron 1 of 13 | XP_016867439.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CNTNAP2 | ENST00000361727.8 | c.98-13496G>C | intron_variant | Intron 1 of 23 | 1 | NM_014141.6 | ENSP00000354778.3 | |||
| CNTNAP2 | ENST00000625365.2 | c.98-13496G>C | intron_variant | Intron 2 of 3 | 5 | ENSP00000485955.1 | ||||
| CNTNAP2 | ENST00000637150.1 | n.27-13496G>C | intron_variant | Intron 1 of 8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.353 AC: 53449AN: 151288Hom.: 10979 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
53449
AN:
151288
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.354 AC: 53535AN: 151404Hom.: 11000 Cov.: 29 AF XY: 0.354 AC XY: 26132AN XY: 73916 show subpopulations
GnomAD4 genome
AF:
AC:
53535
AN:
151404
Hom.:
Cov.:
29
AF XY:
AC XY:
26132
AN XY:
73916
show subpopulations
African (AFR)
AF:
AC:
23663
AN:
41284
American (AMR)
AF:
AC:
3474
AN:
15218
Ashkenazi Jewish (ASJ)
AF:
AC:
1087
AN:
3464
East Asian (EAS)
AF:
AC:
1531
AN:
5136
South Asian (SAS)
AF:
AC:
1534
AN:
4766
European-Finnish (FIN)
AF:
AC:
3960
AN:
10422
Middle Eastern (MID)
AF:
AC:
84
AN:
292
European-Non Finnish (NFE)
AF:
AC:
17305
AN:
67816
Other (OTH)
AF:
AC:
701
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1539
3078
4617
6156
7695
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
490
980
1470
1960
2450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.